Overview
This glossary defines the clinical, research, legal and community terms used across the detrans.ai wiki. Each entry gives a short, neutral definition and links to the page that covers the term in depth. Where trans and detransitioner communities use the same word differently, or where a term is itself disputed, the entry says so briefly.
A few notes on how to read it:
- Entries are alphabetical, with abbreviations listed under their own letters (for example AGP under A, with a pointer to the full term). Numbers and symbols are ignored when sorting.
- "Trans usage" and "detrans usage" describe common patterns in each community's online spaces, not the views of every member. Neither community speaks with one voice.
- Many terms are contested. Some were coined as clinical labels and later rejected by the people they describe; others began as community slang and are now used as insults. A definition here explains what a word is used to mean. It does not endorse the framing behind it.
- Language on this site. The wiki says "male" and "female" (or "born male", "born female") rather than "assigned male/female at birth", and "trans-identified" where a person's own description is the point. See AMAB / AFAB below for why.
Several terms have no settled definition even in the research literature. Detransition is the main example: studies define it narrowly (stopping medical treatment) or broadly (stopping treatment and no longer identifying as trans), and the choice changes every statistic built on it (MacKinnon et al. 2023; Expósito-Campos 2021).
A
AAP: an abbreviation with two unrelated meanings on this wiki. (1) Autoandrophilia (see below). (2) The American Academy of Pediatrics, the main US professional body for paediatricians, whose 2018 policy statement endorsed the gender-affirmative model for minors. See American Academy of Pediatrics.
ADHD (attention-deficit/hyperactivity disorder): a neurodevelopmental condition marked by inattention, impulsivity or hyperactivity. It appears more often than expected among gender-referred young people, and some detransitioners link restlessness or impulsive decisions to their transition. See ADHD and mental health.
Affirmation model / gender-affirming care: an approach in which clinicians accept a person's stated gender identity and support social, hormonal or surgical transition if wanted. "Gender-affirming care" is the umbrella term used by WPATH and many medical bodies; critics argue that the phrase presents a contested treatment as settled, and some detransitioners use "affirmation-only" for care in which their identity was never questioned. See evidence reviews and informed consent.
AGP: see autogynephilia.
AMAB / AFAB ("assigned male / female at birth"): phrases common in trans communities for a person's sex. Supporters say they acknowledge that sex is recorded at birth; critics, including some detransitioners, object that "assigned" implies an arbitrary choice rather than an observation of the body. This wiki uses "male" and "female" instead. See intersex and DSDs.
Ambiguous loss: grief for someone who is still alive but feels lost, a concept from family therapy. Some parents and partners use it to describe a loved one's transition, and some detransitioners use it for their own former self. See ambiguous loss and grief.
Anti-androgen: a drug that blocks or lowers testosterone, used with estrogen in males who transition. Common examples are spironolactone, cyproterone acetate (CPA) and bicalutamide; each has its own risks. See estrogen and testosterone blockers in males.
Atrophy (vaginal or urogenital): thinning and drying of vaginal and urinary tract tissue, which can follow long-term testosterone use in females or removal of the ovaries. It can cause pain, infections and painful sex. See testosterone in females and sexual function.
Autism / ASD (autism spectrum disorder): a lifelong neurodevelopmental condition affecting social communication, with restricted interests and sensory differences. Autistic traits are over-represented among gender-referred youth and detransitioners, and the Cass Review recommended screening for them (Cass 2024). See autism.
Autoandrophilia (AAP): a proposed female counterpart to autogynephilia: sexual arousal at the idea of oneself as male. Blanchard drafted it as a DSM-5 specifier and later said he doubted it existed; some female detransitioners nonetheless describe the pattern in themselves, while many trans men reject the label. See autoandrophilia.
Autogynephilia (AGP): Ray Blanchard's 1989 term for a male's sexual arousal at the thought or image of himself as a woman. In his typology it is the main motive in males who transition and are not exclusively attracted to men. Trans communities widely reject it as stigmatising and unscientific; some detransitioned men accept it as an accurate description of their own experience. See autogynephilia.
Autoheterosexual: an umbrella term, popularised by the writer Phil Illy, covering both autogynephilia and autoandrophilia. See meta-attraction.
B
BDD (body dysmorphic disorder): a preoccupation with perceived flaws in appearance that others barely notice. Some detransitioners believe body dysmorphia or an eating disorder was mistaken for gender dysphoria. See body dysmorphia and eating disorders.
Bell v Tavistock: a 2020 judicial review in England brought by Keira Bell, who had been given puberty blockers as a teenager. The High Court ruled that under-16s were unlikely to be able to consent to blockers; the Court of Appeal overturned that ruling in 2021. See Bell v Tavistock.
Bicalutamide: an anti-androgen drug that blocks testosterone receptors, used off-label in some males who transition. It carries a risk of liver injury. See estrogen and testosterone blockers in males.
Binder / binding: a tight compression garment worn by females to flatten the chest, and the practice of wearing one. Binding is common among trans-identified girls and young women, and is linked to back pain, breathing problems and skin damage, especially with long hours of use. See chest binding.
Blanchard typology: a theory by the Canadian sexologist Ray Blanchard that males who transition fall into two groups: exclusively male-attracted ("homosexual transsexuals") and others, whose transition he linked to autogynephilia. It remains one of the most disputed ideas in the field. See Blanchard's typology.
Blockers: in everyday use, short for puberty blockers (see below). In males on estrogen it can also mean testosterone blockers (anti-androgens).
Bone mineral density (BMD): a measure of how much mineral the bones hold, and a marker of fracture risk. Puberty blockers stop the normal gain in bone density during adolescence, and stopping hormones after removal of the gonads can also weaken bones. See bone health and puberty blockers.
Born in the wrong body: the idea that a person's mind or brain belongs to one sex while their body belongs to the other. It was a common explanation in older transsexual narratives. Many trans people now describe themselves differently, and some detransitioners say the belief shaped their decisions before they let it go. See born in the wrong body.
Borderline personality disorder (BPD): a condition involving unstable mood, relationships and self-image, often with intense fear of abandonment. Its core feature, identity disturbance, can overlap with shifting gender identity. See borderline personality and identity disturbance.
Bottom surgery: informal name for genital surgery, such as vaginoplasty, phalloplasty or metoidioplasty. See transition surgery.
Breast augmentation: surgery to enlarge the breasts with implants or fat grafting, chosen by some males who transition when estrogen alone gives little growth. See breast augmentation.
Butch: a lesbian whose style or manner is masculine. Several detransitioned women describe having reinterpreted butch or gender non-conforming lesbianism as being a trans man, and later reclaiming the word. See lesbian feminism and internalised homophobia.
C
CAH (congenital adrenal hyperplasia): an inherited condition in which the adrenal glands make too much androgen, which can masculinise the genitals of female babies. It is one of the differences of sex development (DSDs), and studies of affected girls are used in debates about prenatal hormones and gender. See intersex and DSDs.
Cass Review: an independent review of NHS gender identity services for children and young people in England, led by the paediatrician Hilary Cass and published in April 2024. It found the evidence for puberty blockers and cross-sex hormones in young people "remarkably weak" and recommended holistic assessment and caution (Cass 2024). See evidence reviews.
Cis / cisgender: a word for people whose gender identity matches their sex. Trans communities use it as the neutral counterpart to "transgender"; some detransitioners and gender-critical writers reject it, saying it implies everyone has an inner gender identity. Detransitioners are sometimes called "cis people who were confused" by trans critics, which many find dismissive. See gender identity beliefs and backlash against detransitioners.
Clocked: slang for being recognised as trans, or as one's actual sex, by a stranger. Fear of being clocked is a recurring source of strain in transition, and some detransitioners describe the constant vigilance as part of why they stopped. See passing and stealth.
Comorbidity: the presence of two or more conditions in the same person at once. Gender-referred youth and adults show high rates of depression, anxiety, autism and other conditions, and whether these are causes, effects or coincidences of gender distress is one of the main open questions. See mental health.
Confounding: in research, a hidden factor that affects both a treatment and an outcome and so distorts the apparent link between them. For example, young people who receive hormones may also receive more mental health care. See reading the research.
Conversion therapy / conversion practices: attempts to change a person's sexual orientation or, in newer laws, their gender identity. The research term for the gender version is gender identity change efforts (GICE). Whether exploratory therapy for gender distress counts as conversion therapy is fiercely disputed; many detransitioners say questioning their identity is not the same as trying to change it. See conversion therapy laws and gender exploratory therapy.
Core and non-core detransition: a typology proposed by Expósito-Campos. Core (primary) detransition follows a change in identity: the person no longer identifies as trans. Non-core (secondary) detransition is stopping or reversing transition for external reasons, such as health or discrimination, while still identifying as trans (Expósito-Campos 2021). See detransition.
Cotton ceiling: a phrase from a 2012 workshop title, used about lesbians' dating boundaries towards trans women. Some trans activists used it to describe exclusion; many lesbians, including some detransitioned women, heard it as pressure to accept partners they are not attracted to. See lesbian feminism.
Cracking (an egg): see egg.
Cross-sex hormones: hormones of the opposite sex given to change secondary sex characteristics: testosterone for females, estrogen (usually with an anti-androgen) for males. Trans communities more often call this HRT or gender-affirming hormones. See cross-sex hormones.
Cult: a word some detransitioners use for the trans communities they left, pointing to love-bombing, thought-stopping phrases and shunning of leavers. Trans users reject the comparison, and the term is a description of experience rather than a technical finding. See cult accusations.
Cyproterone acetate (CPA): an anti-androgen and progestogen widely used outside the US to lower testosterone in males who transition. High doses over years are linked to meningioma, a usually benign brain tumour. See estrogen and testosterone blockers in males.
D
DARE study (Detransition Analysis, Representation, and Exploration): a large US and Canadian survey of 957 people who had detransitioned, reporting from 2025. Roughly a quarter said they had stopped involuntarily, for example because of cost or access. See retransition and rates and prevalence.
Deadname: trans-community term for the name a person used before transition. It frames the old name as belonging to someone who has died. Some detransitioners and families find that framing painful, and many detransitioners return to their birth name. See names and pronouns and ambiguous loss.
Depersonalisation / derealisation: feeling detached from oneself (depersonalisation) or from the world (derealisation). Some detransitioners say these dissociative states were read as gender dysphoria. See dissociation and depersonalisation.
Desistance / desister: letting go of a trans identity or gender dysphoria without having medically transitioned, or the person who does so. In research it mostly describes children whose gender distress resolves by adulthood; in follow-ups of gender-referred boys, a large majority desisted (Singh et al. 2021). Some trans commentators reject the term, arguing those children were never trans. See desistance.
In community use the line between desisting and detransitioning is usually drawn at medical treatment:
Desist: someone who identified as trans (potentially socially transitioned) but never underwent a medical transition and decided to re-identify with their birth sex would be described as someone who has “desisted” —warpdusted, detrans female
Detrans / detransitioner: a person who has detransitioned. On r/detrans the word usually also means no longer identifying as trans; elsewhere it can include people who stop treatment but stay trans-identified. Some detransitioners insist detransition is an action, not an identity. See detransition and r/detrans vs r/actual_detrans.
Detransition: stopping or reversing a gender transition socially, legally, medically, or in any combination (MacKinnon et al. 2023). There is no agreed research definition, which is one reason estimates of how common it is vary so widely. See detransition and rates and prevalence.
Dilation: regularly inserting a rigid form (a dilator) into a surgically created vagina to stop it narrowing or closing. It is needed for life after vaginoplasty. See vaginoplasty.
DIY hormones: hormones obtained and taken without a prescription, usually bought online. Some trans people see them as a response to waiting lists and gatekeeping; detransitioners who used them often describe no medical oversight at all. See DIY hormones.
DSD (differences or disorders of sex development): conditions in which the development of chromosomes, gonads or genitals is atypical, sometimes called intersex. They are often cited in debates about whether sex is binary; on this wiki the medical details are kept separate from claims about gender identity. See intersex and DSDs.
DSM (Diagnostic and Statistical Manual of Mental Disorders): the American Psychiatric Association's diagnostic manual. DSM-IV used gender identity disorder; DSM-5 (2013) replaced it with gender dysphoria. See gender dysphoria.
Dutch protocol: the treatment model developed in Utrecht and Amsterdam in the 1990s and 2000s: puberty blockers from about age 12 for carefully screened adolescents, cross-sex hormones at about 16, and surgery at 18. Its two small follow-up studies became the main evidence for youth transition and have been heavily criticised since about 2019. See the Dutch protocol.
Dysphoria: see gender dysphoria.
E
E: community shorthand for estrogen, especially as a transition hormone ("on E"). See estrogen.
Egg: trans-community slang for a person who is trans but does not yet know it. Cracking is the moment of realisation, and hatching is sometimes used for what follows; "egg_irl" is a popular subreddit of memes. Trans users often describe the metaphor as a joyful account of self-discovery, while many detransitioners see it as a way of reading ordinary gender non-conformity as hidden transness. See egg cracking.
The two views of the same word:
Mine was a real clanger. Lightning strike. Even given I’ve been wearing women’s clothes for ‘fun’ since I was a teenager…. I imagine it’s actually pretty common to go years and years not actually recognising the truth. —josieunderscore, trans woman (MTF)
Why oh why can't someone wear masculine clothing and still be a woman which she is? Same goes for any man that likes femininity whether it's makeup or clothing. It's seen as progressive when it's just what? Extremely sexist? —mirayami, desisted female
Embodiment: a philosophical idea that a person is a body rather than a mind that has one. Some detransitioners use it to describe making peace with their sex. See embodiment.
Endocrine Society guideline: clinical practice guidelines on hormone treatment for gender dysphoria from the US Endocrine Society, published in 2009 and revised in 2017 (Hembree et al. 2017). Critics note that the evidence behind its recommendations was rated low or very low quality. See the Endocrine Society guideline.
Estrogen (estradiol): the main female sex hormone, given to males who transition, usually with an anti-androgen. Its effects include breast growth, fat redistribution and reduced fertility; risks include blood clots. See estrogen and testosterone blockers in males and stopping estrogen.
Euphoria: see gender euphoria.
Exploratory therapy: see gender exploratory therapy.
F
Fa'afafine: a Samoan word, "in the manner of a woman", for males who live in a feminine social role. It is one of several Pacific terms grouped under the acronym MVPFAFF. Its use as evidence for Western gender identity ideas is disputed. See Pacific third gender cultures.
Facial feminisation surgery (FFS): a set of operations that reshape the brow, jaw, chin, nose or hairline to look more female. See facial feminisation.
Fertility preservation: freezing eggs, sperm or tissue before treatment that may cause infertility. Puberty blockers followed directly by cross-sex hormones can leave no mature eggs or sperm to freeze. See fertility.
FTM / MTF: "female to male" and "male to female", the direction of a transition. Also used as identity labels and in subreddit names (r/ftm, r/MtF). See medical transition.
FTMTF / MTFTM: "female to male to female" and "male to female to male": shorthand used by detransitioners for the full journey. Variants such as FTNBTF (female to non-binary to female) also appear. See detransition.
G
Gatekeeping: assessments or waiting periods a person must pass before receiving transition treatment. Trans communities often use it critically, for barriers they see as unnecessary; many detransitioners say they wish there had been more of it, or that the assessments they had were too easy to pass. See true trans and gatekeeping and informed consent.
GD: short for gender dysphoria.
Gender-critical: a view, mainly within feminism, that sex is real and politically important, and that "gender" is a set of social stereotypes rather than an inner identity. Its supporters see it as defending sex-based rights; trans activists often see it as hostile to trans people (see TERF). Some detransitioners come to share it; others reject it. See gender-critical feminism.
Gender dysphoria: distress caused by a felt mismatch between one's sex and one's sense of gender. It is also the DSM-5 diagnosis. Some trans people see it as the core of being trans; others, and many detransitioners, describe dysphoria that later turned out to come from trauma, sexuality, autism or body image. See gender dysphoria and reframing dysphoria.
Gender euphoria: the positive feeling of being seen as, or living as, one's identified gender. Some trans communities treat it as sufficient reason to transition; some detransitioners describe euphoria that faded or that they later read as novelty or relief from other problems. See gender as an explanatory framework.
Gender exploratory therapy (GET): talk therapy that explores where gender distress comes from before any decision on transition, without a fixed goal of affirming or changing identity. It has no agreed manual and little trial evidence; critics call it a form of conversion therapy, a charge its practitioners reject. See gender exploratory therapy and finding a therapist.
Gender fluidity / genderfluid: an identity in which a person's felt gender changes over time. See gender fluidity.
Gender identity: a person's inner sense of being a man, a woman, both or neither. Whether everyone has one, and whether it should outrank sex in law and medicine, is the central dispute this wiki covers. See gender identity beliefs.
Gender incongruence: the term used in the World Health Organization's ICD-11 (in effect from 2022) for a marked mismatch between experienced gender and sex. ICD-11 moved it out of the mental disorders chapter. See gender dysphoria.
Gender non-conformity (GNC): behaviour, interests or appearance that do not match the stereotypes of one's sex, such as tomboyish girls or feminine boys. Many detransitioners say they were GNC and came to understand that this did not mean they were the other sex. See gender non-conformity without labels.
GenderGP: an online gender clinic founded by Helen and Michael Webberley, which prescribed hormones to UK patients, including minors, from outside the NHS. See GenderGP.
Gender Recognition Certificate (GRC): a certificate under the UK Gender Recognition Act 2004 that changes a person's legal sex and allows a new birth certificate. It requires a diagnosis of gender dysphoria and two years in the "acquired gender", and the Act has no route for reversing it. See changing legal sex back.
Genspect: an international organisation that questions the affirmation model and supports a psychological, non-medical approach to gender distress. Supporters see it as a voice for caution; critics see it as an anti-trans advocacy group. See gender exploratory therapy.
GIC (gender identity clinic): a specialist service that assesses and treats gender dysphoria, especially an NHS adult clinic. See gender clinics and clinicians.
GIDS (Gender Identity Development Service): the NHS service for children and young people in England, run by the Tavistock and Portman NHS Foundation Trust. It closed at the end of March 2024 after the Cass Review and was replaced by regional services. See the Tavistock GIDS.
Gillick competence: the principle, from a 1985 House of Lords ruling, that a child under 16 in England and Wales can consent to medical treatment if they understand it well enough. It was central to Bell v Tavistock. See informed consent.
GnRH agonist (GnRHa): gonadotropin-releasing hormone agonist, the class of drugs used as puberty blockers (such as triptorelin or leuprorelin). See puberty blockers.
GRA: the UK Gender Recognition Act 2004. See Gender Recognition Certificate.
GRADE (Grading of Recommendations, Assessment, Development and Evaluations): the standard system for rating how certain a body of evidence is, from high to very low. Most systematic reviews of youth gender medicine have rated the evidence low or very low certainty. See reading the research.
GRS / SRS: gender (or sex) reassignment surgery, an older umbrella term for genital surgery. See transition surgery.
H
Hatching: see egg.
HBIGDA: the Harry Benjamin International Gender Dysphoria Association, founded in 1979 and renamed WPATH in 2007. See history of gender medicine.
Hijra: a long-established community in South Asia of people, mostly born male, who live in a feminine role, sometimes after ritual castration (nirvaan). India's Supreme Court recognised a "third gender" in the 2014 NALSA ruling. See India's hijras.
HRT: "hormone replacement therapy". In trans communities, the usual name for cross-sex hormones. Critics, including some detransitioners, point out that nothing is being replaced, since the person's own hormones were normal. See cross-sex hormones.
HSTS (homosexual transsexual): Blanchard's term for a male who transitions and is exclusively attracted to men, "homosexual" being relative to sex. Many trans people today would say "straight trans woman" and regard the term as offensive. See HSTS.
Hysterectomy: surgical removal of the uterus, often with the ovaries (oophorectomy). In females who transition it ends any chance of pregnancy and, with the ovaries removed, means lifelong hormone dependence. See hysterectomy.
I
Iatrogenic harm: harm caused by medical treatment itself. Detransitioners use it for lasting effects of transition they were not properly warned about. See iatrogenic harm.
ICD-11: the eleventh edition of the World Health Organization's International Classification of Diseases, in effect from 2022. It uses gender incongruence. See gender dysphoria.
Identity disturbance: a persistently unstable self-image or sense of self, a core feature of borderline personality disorder. See borderline personality and identity disturbance.
Informed consent model: a way of providing hormones, mainly to adults in US community clinics, in which a patient who understands the risks can start without a mental health assessment. Supporters see it as respecting autonomy; many detransitioners say the consent they gave was not truly informed. See informed consent and history of gender medicine.
Internalised homophobia / misogyny / misandry: negative attitudes towards one's own sexuality (homophobia), towards being female (misogyny) or towards being male (misandry), absorbed from the surrounding culture. Many detransitioners name one or more of these as a reason they transitioned. See internalised prejudice.
Intersex: see DSD.
K
Kathoey: a Thai term for males who live in a feminine role, sometimes translated as "ladyboy". See Thailand.
Karolinska: the Swedish university hospital whose youth gender service changed course in 2021, limiting hormones for minors to research settings, after media investigations and a review of evidence. See Sweden and Karolinska.
L
LGB / LGBT / LGBTQ+: abbreviations for lesbian, gay and bisexual, with T for transgender and Q for queer or questioning. Some detransitioners and gay rights groups argue that sexual orientation and gender identity have different interests and should not always be grouped. See the gay rights movement and gender identity.
Loss to follow-up: when people in a study stop being tracked, so their outcomes are unknown. In gender medicine it is a major reason detransition rates are uncertain, since people who stop treatment often stop contacting their clinic. See rates and prevalence and reading the research.
M
Mastectomy / top surgery: removal of breast tissue to give a flat, male-looking chest, the most common surgery among females who transition. It is irreversible; reconstruction is possible but does not restore the original breast. See mastectomy and breast reconstruction.
Medical transition: using hormones, puberty blockers or surgery to make the body more like that of the other sex. See medical transition.
Mermaids: a UK charity supporting gender-questioning children and their families, criticised for giving binders to minors and investigated by the Charity Commission. See Mermaids.
Meta-attraction: in Blanchardian thinking, attraction to a partner because being desired by them confirms a cross-sex self-image, rather than attraction to the partner's body. Also called pseudo-bisexuality. See meta-attraction.
Metoidioplasty: genital surgery for females on testosterone that releases the enlarged clitoris to form a small penis, sometimes with urethral lengthening. See metoidioplasty.
Mimetic desire: René Girard's idea that people learn what to want by imitating others. Some detransitioners use it to explain how trans identities spread in friendship groups. See mimetic desire.
Minority stress: a model, developed for lesbian, gay and bisexual health, holding that stigma and rejection cause higher rates of mental illness in minority groups. It is often used to explain poor mental health among trans people; critics argue it is applied without testing other explanations. See causes and correlates and internalised prejudice.
Misgender: to refer to someone with words for a sex they do not identify as. For a detransitioner, being "misgendered" can mean being called by their former trans name or pronouns. See names and pronouns.
MVPFAFF: an acronym for Pacific terms for males in a feminine role (māhū, vakasalewalewa, palopa, fa'afafine, akava'ine, fakaleiti and fakafifine). See Pacific third gender cultures.
N
Neovagina: a vagina-like canal surgically constructed in vaginoplasty, usually from penile and scrotal skin. See vaginoplasty.
NICE evidence reviews: reviews of puberty blockers and cross-sex hormones for young people, commissioned by NHS England from the National Institute for Health and Care Excellence and published in 2021. Both rated the evidence very low certainty. See evidence reviews.
Nirvaan: the ritual castration traditionally undergone by some hijras. See India's hijras.
Non-binary: an identity outside the categories man and woman. Some people move from a binary trans identity to non-binary on the way to detransition, and some detransitioners argue that it keeps the same link between personality and sex that they later rejected. See non-binary identities.
O
OCD (obsessive-compulsive disorder): a condition of intrusive, distressing thoughts and repetitive acts to relieve them. Some people describe obsessive doubt about their gender, sometimes called gender-themed OCD, and how it was handled. See OCD.
Oophorectomy: surgical removal of the ovaries, often done with hysterectomy. See hysterectomy.
Orchiectomy: surgical removal of the testes, which ends natural testosterone production and fertility. See orchiectomy.
P
Packer / packing: a prosthetic worn in the underwear to create a male bulge, and the practice of wearing one. See social transition.
Passing: being taken for the sex one presents as. Some detransitioners describe passing as never-ending work; for others, passing well did not resolve their distress. See passing and stealth and when distress persisted.
Peak trans: a phrase, mainly from gender-critical spaces, for the moment someone stops accepting gender identity ideas. Some detransitioners use it about their own turning point; trans users tend to hear it as a hostile phrase. See changing beliefs and realisation moments.
Grudge lurking at “TERFs” on Radical Feminist sites is what brought me to my “peak trans” experience (the point of no return for being able to accept trans ideology). —L82Desist, detrans female
Persistence / persister: continued gender dysphoria or trans identity over time, especially from childhood into adolescence; the opposite of desistance. See desistance.
Phalloplasty: multi-stage surgery to build a penis, usually from forearm or thigh tissue, for females who transition. It has high complication rates. See phalloplasty.
Pipeline: critics' term for the pathway from social transition to puberty blockers, hormones and surgery, implying each step makes the next more likely. Supporters argue that people continue because their identity is stable. See the transition pipeline.
Pronouns: words such as he, she and they. Changing them is a central part of social transition, and changing them back is part of social detransition. See names and pronouns.
Puberty blockers: drugs (GnRH agonists) that pause puberty by switching off the hormonal signals that drive it. Supporters describe them as a reversible pause; critics, and some detransitioners given them young, point to effects on bone, fertility, sexual development and the near-universal move on to cross-sex hormones. See puberty blockers.
Q
Queer theory: an academic approach, associated with Judith Butler and others, that treats sex and gender categories as socially produced and unstable. See queer theory.
Questioning: being unsure of one's gender identity or sexuality. See when a child says they are trans.
R
r/detrans and r/actual_detrans: the two main Reddit communities for detransitioners. r/detrans is the older and larger, where many members no longer identify as trans; r/actual_detrans welcomes people still trans-identified and bans gender-critical views. See r/detrans vs r/actual_detrans.
Realisation moment: the point at which a person comes to see their transition differently, sometimes sudden and sometimes gradual. See realisation moments.
Regret: the feeling that a transition, or a particular step in it, was a mistake. Regret and detransition overlap but are not the same: some people regret without detransitioning, and some detransition without regret (Expósito-Campos 2021). See transition regret.
Re-identify: to come to identify again with one's sex, or as lesbian, gay or bisexual, after a trans identity (MacKinnon et al. 2023). See detransition.
Retransition: resuming a gender transition after having detransitioned. Some people use the word for the opposite, which causes confusion. See retransition.
ROGD (rapid-onset gender dysphoria): a term introduced by Lisa Littman in 2018 for gender dysphoria that seems to appear suddenly in adolescence, often in a social context, in young people with no childhood signs (Littman 2018). It is a hypothesis, not a diagnosis. Some clinic data have been read as not supporting it (Bauer et al. 2022), while many detransitioned women recognise their own story in it. See rapid-onset gender dysphoria.
S
SBU: the Swedish Agency for Health Technology Assessment and Assessment of Social Services, whose 2019 and 2022 reviews found the evidence for youth gender treatment weak. See Sweden and Karolinska.
SEGM (Society for Evidence-Based Gender Medicine): a group of clinicians and researchers critical of current youth gender medicine. Supporters see it as a voice for rigorous evidence; critics describe it as an advocacy group. See gender exploratory therapy and Wikipedia.
Self-ID (self-identification): a legal system in which a person can change their legal sex by declaration, without a medical diagnosis. See sex and gender identity law.
Sex-based rights: rights and protections defined by sex rather than gender identity, such as single-sex spaces or sports. The phrase is central to gender-critical feminism. See gender-critical feminism.
Social contagion: the spread of a behaviour, belief or identity through peers and media. Its role in the recent rise of trans identification among teenagers is one of the most disputed questions in the field. See social contagion and peer influence and demographic shift.
Social transition: changing name, pronouns, clothing or presentation to live as another gender, without medical treatment. See social transition and young children.
SOC / SOC7 / SOC8: WPATH's Standards of Care. SOC7 (2011–2012) set minimum ages for some treatments; SOC8 (2022) removed most of them. See the WPATH Files and evidence reviews.
Spironolactone: a diuretic used as an anti-androgen in males who transition, especially in the US. It can raise potassium levels. See estrogen and testosterone blockers in males.
Stealth: living as one's identified gender without others knowing one has transitioned. See passing and stealth.
Sunk cost: the pull to keep going because of what has already been invested. Some detransitioners say the time, money, surgery and relationships already spent made it harder to admit doubts. See changing beliefs and transition regret.
Systematic review: a review that searches for, appraises and summarises all studies on a question using pre-set methods. It differs from a clinical guideline, which makes recommendations and may weigh expert opinion. See reading the research.
T
T: community shorthand for testosterone ("on T"). See testosterone.
Tanner stages: a five-stage scale of physical development in puberty, from stage 1 (pre-pubertal) to stage 5 (adult). The Dutch protocol started blockers at Tanner stage 2–3. See the Dutch protocol.
TERF ("trans-exclusionary radical feminist"): a label for feminists who hold that sex, not gender identity, defines women. Those it is applied to generally consider it a slur and prefer "gender-critical". Some detransitioners report being called TERFs simply for speaking about their experience. See gender-critical feminism and backlash against detransitioners.
Testosterone: the main male sex hormone, given to females who transition. Some effects, such as a deeper voice, facial hair and clitoral growth, are largely permanent. See testosterone in females and stopping testosterone.
Third gender: social categories in some cultures for people who are neither men nor women in the usual sense, such as hijra, fa'afafine or kathoey. How far they support Western gender identity ideas is disputed. See third gender cultures.
Top surgery: see mastectomy. For males, it can mean breast augmentation.
TRA ("trans rights activist"): a label used, mostly by critics, for campaigners for trans rights. It is often used pejoratively in gender-critical and some detransitioner spaces. See communities.
Trans broken arm syndrome: trans-community phrase for clinicians blaming any symptom on a patient's trans status or hormones. Some detransitioners describe the opposite: real side effects being dismissed as unrelated. See health complications.
Transfem / transmasc: umbrella terms for trans people moving towards femininity (born male) or masculinity (born female), including some non-binary people. See non-binary identities.
Transgender / trans: an umbrella term for people whose gender identity differs from their sex. Older clinical writing used transsexual for those who medically transition. See gender identity beliefs.
Trans-identified: a phrase for people who identify as trans, used on this wiki where the identification itself, rather than any claim about the person's nature, is the point. Some trans people find it distancing. See detransition.
Transition: the process of living as another gender, socially, legally or medically. See social transition and medical transition.
Transtrender: an insult for someone said to adopt a trans identity as a trend. It is used within trans communities, often by transmedicalists, and is sometimes thrown at detransitioners. See true trans.
Trans widow: a term some women use for themselves after a husband transitions. It is contested, and critics see it as hostile. See partners and spouses.
Trauma: lasting psychological harm from distressing events such as abuse or assault. Many detransitioners link trauma to their wish to escape their sex. See trauma.
True trans: the idea that some people are "really" trans and others are not. Trans critics often say detransitioners were "never really trans"; detransitioners commonly reject that claim as a way of avoiding scrutiny. See true trans.
Truscum / transmedicalist: someone who holds that being trans requires gender dysphoria and usually medical transition. Tucute is the opposing slang label, for those who say identity alone is enough. Both began as insults. See true trans and community disillusionment.
Tucking: hiding the penis and testicles between the legs to create a flat appearance. See social transition.
U
US Transgender Survey (USTS): a large online survey of trans-identified adults in the US, run in 2015 (27,715 respondents) and 2022. It is a convenience sample, recruited through trans networks, so it cannot tell how common outcomes are among all who transition. See reading the research.
V
Vaginoplasty: genital surgery for males that removes the testes and builds a vulva and usually a neovagina from penile and scrotal tissue. It is irreversible and needs lifelong dilation. See vaginoplasty.
W
Watchful waiting: the older approach to gender-distressed children, waiting to see whether distress resolves without transition. Its critics call it outdated; its supporters point to high desistance rates in older follow-ups. See history of gender medicine and desistance.
WPATH (World Professional Association for Transgender Health): the international professional body that publishes the Standards of Care. The 2024 "WPATH Files", leaked internal discussions, raised questions about consent and evidence. See the WPATH Files.
Related pages
- Detransition
- Why they transitioned: causes and correlations
- Why they detransitioned: reasons and realisations
- Medical transition
- Social transition
- Gender identity beliefs
- Feminism, sex and gender identity
- Online communities
- Parents and families
- How to read gender medicine research
- History of gender medicine
- History of detransition
References
- Bauer, G. R. et al. (2022). Do Clinical Data from Transgender Adolescents Support the Phenomenon of "Rapid Onset Gender Dysphoria"? Journal of Pediatrics. study page, source.
- Cass, H. (2024). Independent review of gender identity services for children and young people: Final report. The Cass Review. study page, source.
- Expósito-Campos, P. (2021). A Typology of Gender Detransition and Its Implications for Healthcare Providers. Journal of Sex & Marital Therapy. study page, source.
- Hembree, W. C. et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. study page, source.
- Littman, L. (2018). Parent reports of adolescents and young adults perceived to show signs of a rapid onset of gender dysphoria. PLOS ONE. study page, source.
- MacKinnon, K. R. et al. (2023). Detransition needs further understanding, not controversy. BMJ. study page, source.
- Singh, D., Bradley, S. J. and Zucker, K. J. (2021). A Follow-Up Study of Boys With Gender Identity Disorder. Frontiers in Psychiatry. study page, source.
Last updated:
Suggest an Article or an Improvement
Spotted something missing, unclear or wrong on this page, or have an idea for a related article? Let us know and we'll take a look.
Related pages:
- Why They Transitioned: Causes and Correlations
What led detransitioners to transition in the first place: autism, trauma, mental illness, internalised homophobia and misogyny, and how they interact.
- Online Communities, Social Influence and Gender Identity
How some people learn and reinforce gender identities in groups and online, the contagion vs acceptance debate, and what detransitioners say about leaving.
- Detransition: Meaning, Reasons, and Life Afterward
What detransition means, how it differs from desistance and retransition, why people reverse transitions, trans vs detrans views, and unknown rates.
- Feminism, Sex and Gender Identity
An overview of feminism's waves and strands, the split over whether 'woman' means sex or gender identity, and why feminist ideas matter to detransitioners.
- Gender Identity Beliefs: Ideas, Evidence and Critique
Where the idea of an inner gender identity came from, the beliefs built on it, the evidence and philosophy behind them, and what detrans and trans people say.
- Medical Transition: Evidence, Risks and Experiences
How medical transition works—blockers, hormones, surgery—for adolescents and adults, the weak evidence, known risks, and what detransitioners report.
- Parents and Families: Guidance and Experiences
A guide for parents, partners and relatives of someone transitioning or detransitioning: where to start, what the evidence says, and what helped families.
- Why They Detransitioned: Reasons and Realisations
Why some people stop transitioning: health, persisting distress, reframed dysphoria, beliefs, pressure and more, with survey and r/detrans data and limits.
- Social Transition: Names, Pronouns, Schools and Evidence
What social transition involves, whether it is a neutral act or an intervention that locks in identity, the evidence, schools, and detrans experiences.